Long-term high-dose immunoglobulin successfully treats Long COVID patients with pulmonary, neurologic, and cardiologic symptoms
Covid Lists
Clinical and CSF single-cell profiling of post-COVID-19 cognitive impairment
Interferon-λ treatment accelerates SARS-CoV-2 clearance despite age-related delays in the induction of T cell immunity
Long COVID Looks Like Acute Infection in the Brain
Frontiers | Corrigendum: Case Series: Maraviroc and pravastatin as a therapeutic option to treat long COVID/Post-acute sequalae of COVID (PASC)
Study Details | Antiviral Clinical Trial for Long Covid-19 | ClinicalTrials.gov
(16) Post-Viral Trials News (@postviraltrials) / X
RECOVER Clinical Trials | Home
Monoclonal antibody levels and protection from COVID-19
Molecular mechanisms of SARS-CoV-2 resistance to nirmatrelvir
Tenofovir Disoproxil Fumarate Reduces the Severity of COVID-19 in Patients with Chronic Hepatitis B
Broad-spectrum antiviral activity of two structurally analogous CYP3A inhibitors against pathogenic human coronaviruses in vitro
Human Immunodeficiency Virus Status, Tenofovir Exposure, and the Risk of Poor Coronavirus Disease 19 Outcomes: Real-World Analysis From 6 United States Cohorts Before Vaccine Rollout | Clinical Infectious Diseases | Oxford Academic
Luteolin: A promising natural agent in management of pain in chronic conditions
Luteolin
Pharmacological Activity of Eriodictyol: The Major Natural Polyphenolic Flavanone
Eriodictyol - an overview | ScienceDirect Topics
TREAT ME Survey: Individual Treatment Results
Fibrin drives thromboinflammation and neuropathology in COVID-19
Monoclonal Antibodies: A Potential Solution For Prolonged COVID Symptoms?
Remission of severe forms of long COVID following monoclonal antibody (MCA) infusions: A report of signal index cases and call for targeted research
Treatment of persistent COVID-19 in two B-cell-depleted patients with the monoclonal antibody Sotrovimab
Long COVID: Some patients may need an immune system boost
Reduced Cell Surface Levels of C-C Chemokine Receptor 5 and Immunosuppression in Long Coronavirus Disease 2019 Syndrome | Clinical Infectious Diseases | Oxford Academic
Degradative Effect of Nattokinase on Spike Protein of SARS-CoV-2
Informing Blacks with Long Covid
Archive - Studies, Surveys, & Supplements
Lumbrokinase, a Fibrinolytic Enzyme, Prevents Intra-Abdominal Adhesion by Inhibiting the Migrative and Adhesive Activities of Fibroblast via Attenuation of the AP-1/ICAM-1 Signaling Pathway
Patient infected with COVID-19 finally cured after 411 days
Real-Time Whole Genome Sequencing to Guide Patient-Tailored Therapy of Severe Acute Respiratory Syndrome Coronavirus 2 Infection | Clinical Infectious Diseases | Oxford Academic
Taurine deficiency as a driver of aging